funded by the National Key R&D Program [2022YFC2305200];China CDC-Tuberculosis Control and Prevention Project [228711]。
Drug-resistant(DR) tuberculosis(TB) is a growing threat to public health[1]. Fluoroquinolone(FQ) antibiotics have long been used as anti-tuberculosis drugs, and their widespread application has led to the development ...